Lipitor (R) (atorvastatin calcium) (80 mg) were more effective than simvastatin in reduction of risk of repeated cardiovascular events in patients with a history of heart attacks.

 

Cardiovascular events included heart attack, impact, and intimate procedures of replacement of blood vessels such as operational of detour. Results have been submitted from the American Heart Association.

 

Patients of heart attack are extremely vulnerable to overcoming even more than cardiovascular events. After such case, the most important problem of the doctor of consideration will be to reduce risk of the following cardiovascular case. This analysis has shown, that Lipitor was more effective than simvastatin in reduction of risk of the current cardiovascular events. Results patients who have already tested cardiovascular benefit of events from Lipitor 80 mg provide the certificate.

 

The analysis is unique, because it has estimated all cardiovascular events which have taken place during a five-year rate of test whereas researches of the majority statin tests are usually limited to an estimation of occurrence of the first case only.

 

The analysis informed, that 1/2 patients had the second cardiovascular case during test. In those patients who consider with Lipitor, there was an essential 20-percent reduction of relative risk of presence that the second case than what consider with simvastatin. The analysis also has found, that 1/3 patients had the third case during test. In those patients who had treatment with Lipitor there was an essential 16-percent reduction of relative risk of presence of that third case in comparison with simvastatin. Full results of this analysis are even more sensible in patients who were a plenty of the supporter to treatment.

 

This unique analysis confirmed benefit long-term Lipitor therapies on 80 mg in patients who had repeated cardiovascular events. By consideration of patients with cardiovascular risk of illness it is important to take into account the clinical data for treatment so that the correct medicine has been chosen for the individual patient.

 

Lipitor is the most ordered therapy lowering cholesterol in the world, almost with 125 million patient years of experience. Lipitor it is supported according to the extensive clinical program of the test involving more than 350 proceeding and finished tests from more than 75000 patients.